CIK 0001130598
- Non-accelerated filer
- Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-26 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +69,984 | 69,984 | ||
| 2015-09-25 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +32,500 | 32,500 | ||
| 2015-04-16 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +32,500 | 32,500 | ||
| 2014-12-18 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +65,000 | 65,000 | ||
| 2013-12-20 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +65,000 | 65,000 | ||
| 2013-07-30 | BANSAL AJAY Chief Financial Officer | Conversion | +23,785 | 43,846 | ||
| 2013-07-30 | BANSAL AJAY Chief Financial Officer | Conversion · Series B Convertible Preferred Stock | −28,181 | 0 | ||
| 2013-07-25 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +5,000 | 5,000 | ||
| 2013-07-25 | BANSAL AJAY Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +40,000 | 40,000 |
Page 1 of 1 · 9 trades